Rate My Professor Lauri Eklund

Eklund's academic interests center on vascular morphogenesis, the interplay between endothelial cells, extracellular matrix, and cell-cell contacts that regulate vascular integrity, and disease mechanisms in vascular anomalies such as venous malformations. His group employs advanced models including microfluidic platforms and human cell-based systems to investigate these processes. Major publications include 'Therapeutic targeting of the angiopoietin-TIE pathway' (2017), 'Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell surface expression' (2022), 'VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Insulin Resistance and Maintains Metabolic Homeostasis' (2016), 'Angiopoietin signaling in the vasculature' (2013), and 'Claudin5 protects the peripheral endothelial barrier in an organ- and segment-specific manner' (2022). These contributions have illuminated therapeutic targets for vascular diseases and garnered substantial citations. Eklund's research receives support from the Academy of Finland, Wihuri Foundation, Sigrid Jusélius Foundation, and European Research Council grants, underscoring his impact in the field of vascular biology.